Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.046 CHF
15.88 M CHF
162.82 M CHF
17.68 M
About Rigel Pharmaceuticals, Inc.
Sector
Industry
CEO
Raul R. Rodriguez
Website
Headquarters
South San Francisco
Founded
1996
Identifiers
3
ISINUS7665597024
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of RIGL is 24.013 CHF — it has increased by 34.81% in the past 24 hours. Watch Rigel Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange Rigel Pharmaceuticals, Inc. stocks are traded under the ticker RIGL.
We've gathered analysts' opinions on Rigel Pharmaceuticals, Inc. future price: according to them, RIGL price has a max estimate of 54.92 CHF and a min estimate of 30.25 CHF. Watch RIGL chart and read a more detailed Rigel Pharmaceuticals, Inc. stock forecast: see what analysts think of Rigel Pharmaceuticals, Inc. and suggest that you do with its stocks.
RIGL reached its all-time high on Aug 7, 2025 with the price of 24.084 CHF, and its all-time low was 17.630 CHF and was reached on Mar 17, 2025. View more price dynamics on RIGL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RIGL stock is 26.12% volatile and has beta coefficient of 1.36. Track Rigel Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Rigel Pharmaceuticals, Inc. there?
Today Rigel Pharmaceuticals, Inc. has the market capitalization of 629.00 M, it has increased by 36.96% over the last week.
Yes, you can track Rigel Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Rigel Pharmaceuticals, Inc. is going to release the next earnings report on Mar 3, 2026. Keep track of upcoming events with our Earnings Calendar.
RIGL earnings for the last quarter are 1.16 CHF per share, whereas the estimation was 0.72 CHF resulting in a 62.27% surprise. The estimated earnings for the next quarter are 0.83 CHF per share. See more details about Rigel Pharmaceuticals, Inc. earnings.
Rigel Pharmaceuticals, Inc. revenue for the last quarter amounts to 55.33 M CHF, despite the estimated figure of 49.29 M CHF. In the next quarter, revenue is expected to reach 52.40 M CHF.
RIGL net income for the last quarter is 22.22 M CHF, while the quarter before that showed 47.30 M CHF of net income which accounts for −53.02% change. Track more Rigel Pharmaceuticals, Inc. financial stats to get the full picture.
No, RIGL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2025, the company has 164 employees. See our rating of the largest employees — is Rigel Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Rigel Pharmaceuticals, Inc. EBITDA is 96.67 M CHF, and current EBITDA margin is 14.74%. See more stats in Rigel Pharmaceuticals, Inc. financial statements.
Like other stocks, RIGL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rigel Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.